Ahuja Kripa, An Miranda, Lio Peter
Eastern Virginia Medical School, Norfolk, Virginia, USA.
University of California, School of Medicine, Irvine, California, USA.
Skin Pharmacol Physiol. 2024;37(4-6):104-108. doi: 10.1159/000541418. Epub 2024 Sep 12.
Topical therapy has been a fundamental part of dermatology, evolving from early ointments to advanced transdermal treatments. These formulations allow for effective management of skin conditions by maximizing local drug delivery and minimizing systemic effects. Modern topical therapies continue to benefit from innovations that improve both efficacy and patient outcomes.
Topical formulations consist of a vehicle and active ingredients, with the vehicle enhancing drug absorption and patient experience. Historically categorized by physical properties, vehicles are vital in drug delivery. Recent innovations, such as nanoemulsions and derma-membrane structures, offer improved skin penetration and therapeutic results, representing significant advancements in topical treatment options.
Topical therapies provide targeted, effective treatment in dermatology with minimal systemic side effects. Vehicle choice is essential to therapy success, and innovations such as nanoemulsions are improving drug delivery and patient care. Ongoing research into novel delivery systems continues to enhance the future of dermatological treatments.
局部治疗一直是皮肤科的基础组成部分,从早期的软膏发展到先进的透皮治疗。这些制剂通过最大限度地提高局部药物递送并最小化全身效应,实现对皮肤疾病的有效管理。现代局部治疗继续受益于提高疗效和患者治疗效果的创新。
局部制剂由载体和活性成分组成,载体可增强药物吸收并改善患者体验。载体历史上按物理性质分类,在药物递送中至关重要。纳米乳剂和真皮膜结构等最新创新技术可改善皮肤渗透和治疗效果,代表了局部治疗选择的重大进展。
局部治疗在皮肤科提供靶向、有效的治疗,全身副作用最小。载体的选择对治疗成功至关重要,纳米乳剂等创新技术正在改善药物递送和患者护理。对新型递送系统的持续研究不断提升皮肤科治疗的未来发展。